PharmaFluidics is now part of Thermo Fisher Scientific, the world leader in serving science.
This acquisition brings about new opportunities to create greater value and strengthens its ability to fulfill Thermo Fisher’s mission, which is to enable customers to make the world healthier, cleaner and safer.
The addition of PharmaFluidics’ μPAC microchip-based chromatography columns complements Thermo Fisher’s portfolio offering to biopharma customers and enhances its ability to meet increasing customer demands for separations in the mass spectrometry workflow. Through this exciting combination, Thermo Fisher will be an even stronger partner—expanding the µPAC products and technology as part of an integrated portfolio to more effectively meet global customer needs.
